- 1. J. Reynolds - PRRT Bad Berka
- (Bad Berka)
- ... type, I was also not going to sit idly by and let someone else coordinate my medical care and I still refuse to do that. After establishing care with oncology and being started on Octreotide LAR injections, ...
- Created on 01 March 2017
- 2. Results from NETTER-1 PRRT Trail Released
- (News)
- The results from the first randomized control trial of PRRT were released today in Vienna, Austria showing increased progression free survival compared to high dose octreotide LAR. PRRT while available ...
- Created on 27 September 2015
- 3. Becca H
- (Rotterdam)
- ... taking a stool softener with you (Senokot S is especially good), in case you need it. It’s also advisable to take pain meds with you, just in case you need them. You’ll need to take your Octreotide subcutaneous ...
- Created on 26 February 2014
- 4. Ga68 - Orphan Drug Announcement
- (In the News)
- BREAKING NEWS – the radiopharmaceutical Gallium-68 (DOTA0-hel-Tyr3) octreotide (Ga-68 DOTATOC) has been designated as an orphan drug by the US Food and Drug Administration (FDA) for the management of neuroendocrine ...
- Created on 20 November 2013
- 5. PRRT Multi-Center Trial Now Open
- (In the News)
- A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1) is now open ...
- Created on 21 July 2013
- 6. Multicenter PRRT Clinical Trial Announced
- (In the News)
- ... parallel-group phase III study. In this study, treatment with 177Lu-DOTA0-Tyr3-Octreotate plus best supportive care (30 mg Octreotide LAR) will be compared to treatment with high dose (60 mg) Octreotide ...
- Created on 20 April 2012
- 7. CCAN NET Cancer Patients Conference Long Island
- (Past Conferences )
- ... in New Orleans Dr. Tom O’Dorisio – University of Iowa Evolution of NETs – from Gastrin in 1905 – Zollinger-Ellison 1955- Radio Peptide Receptor 1967 - Octreotide 1980 - to Theranostics (Baum) ...
- Created on 20 August 2011
- 8. A Soldier's Stor
- (Bad Berka)
- ... Barnes Jewish Hospital in St. Louis, Missouri. My new doctor there ordered several tests for me including the Octreotide scan, CT scan, and blood tests. My tumors were confirmed as Carcinoid with high ...
- Created on 31 May 2011
- 9. Flora
- (Bad Berka)
- ... and some suggested waiting and watching the disease since a medication called octreotide controlled all of Flora's symptoms. Most surgeons felt that Flora's cancer was inoperable because there were too many ...
- Created on 18 April 2011
- 10. FAQs
- (FAQs)
- ... when the tumor burden is still minimal and the radiation therapy can be most effective. Download this article by Doctors Grabowski and Baum for more explanation. Can I be on Octreotide therapy during ...
- Created on 13 April 2011
- 11. 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy
- (In the News)
- ... diarrhea; weight gain in underweight patients; the ability to give up octreotide therapy; and improvement of overall health. Most importantly, the median overall survival of patients from the start of ...
- Created on 07 April 2011
- 12. Elizabeth W.
- (Bad Berka)
- ... I emailed Josh to ask him how to contact the doctor and he copied his response to Dr. Baum. Within a day I had an email from the doctor telling me to get a new Octreotide scan and to send all of my records ...
- Created on 22 March 2011
- 13. PRRT Results
- (PRRT)
- ... to regress and die. In studies by Dr. Kwekkeboom and his colleagues, the duration of therapy response for Y-90 octreotide and for Lu-177 octreotate is reported at more than 30 months. Overall Survival ...
- Created on 21 March 2011
- 14. Who Should Consider PRRT
- (PRRT)
- ... a form of octreotide) is combined with a radionuclide such as Lutetium-177 (LU177) or Yttrium-90 (Y90), it has a strong affinity for the somatostatin receptor subtype-2 that can exist in the NET tumor. ...
- Created on 20 January 2011
- 15. PRRT Background and Types
- (PRRT)
- ... tumors 2cm and larger. In the late 1990s and early 2000s, Doctors started using two other radionuclides that were coupled to Octreotide. These were Yttrium-90 and Lutetium-177. Later some doctors tried ...
- Created on 20 January 2011
- 16. How Does PRRT Work
- (PRRT)
- ... as the magnet and the iron shavings are a somatatostatin analog chemical (Octreotide) to which is bound or attached to some radioactive material (the radionuclide Y90 or LU177). The receptors in the tumors ...
- Created on 20 January 2011
- 17. Information for Referring Physicians
- (General MD)
- ... by OctreoScan or (preferable) by Ga-68 DOTATOC PET/CT. * Renal function and blood counts should be in the normal range. * Small bowel tumors (midgut), progressive under octreotide (Sandostatin, Somatuline) ...
- Created on 19 July 2010
- 18. Food, Dining, Medications and Personal Gear Considerations
- (What to bring)
- ... If the patient is using the Subq form of Octreotide up until the Saturday priot to PRRT, then the patient should bring that medication. It is also suggested that the patient bring some form of anti-nausea ...
- Created on 19 July 2010
- 19. Medical Records and Information Needed
- (Prior Tests)
- ... CT, MRI or Octreotide scans that should exist on CD or DVDs. Depending upon a patient's case history, some historical records could be needed as well. Dr. Baum normally will advise the patient or the ...
- Created on 19 July 2010
- 20. What is PRRT?
- (PRRT)
- Peptide Receptor Radionuclide Therapy (PRRT) is a form of molecular targeted therapy which is performed by using a small peptide (a somatostatin analog similar to octreotide) that is coupled with a ...
- Created on 19 July 2010